Literature DB >> 2573550

The survival of chick retinal ganglion cells in response to brain-derived neurotrophic factor depends on their embryonic age.

A Rodriguez-Tébar1, P L Jeffrey, H Thoenen, Y A Barde.   

Abstract

The survival effects of brain-derived neurotrophic factor (BDNF) on the ganglion cells of the chick retina were studied in vitro at different embryonic ages. We found these effects to be strongly age-dependent: at E5, when the first ganglion cell axons have crossed the optic chiasm, but not yet reached the tectum, ganglion cells survived on a laminin substrate irrespective of the presence or absence of BDNF. At E6, when the axons of the first-generated ganglion cells reached the rostral pole of the tectum, the ganglion cells began to show a dependency on BDNF for survival, but the majority of them were alive after 2 days in vitro in the absence of BDNF. With increasing age, the BDNF dependency for survival increased, and at E11, the majority of the ganglion cells plated were dependent on BDNF for survival. It is at this age that the maximal number of axons can be found in vivo in the optic nerve, the subsequent elimination of ganglion cells and their axons resulting in the loss of hundreds of thousands of them over the next few days. Taken together, these data indicate that retinal ganglion cells depend on BDNF for survival only when their axons have reached their target in vivo. This situation is reminiscent of that described in the peripheral nervous system for the nerve growth factor responsiveness of mouse trigeminal sensory neurons during the period of innervation of their target.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573550     DOI: 10.1016/0012-1606(89)90256-x

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  23 in total

1.  c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis.

Authors:  B Pimentel; C Sanz; I Varela-Nieto; U R Rapp; F De Pablo; E J de La Rosa
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration.

Authors:  Eric V Wong; Samuel David; Michele H Jacob; Daniel G Jay
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 3.  Extracellular matrix and neuronal movement.

Authors:  P Liesi
Journal:  Experientia       Date:  1990-09-15

4.  Neurotrophin-3 antibodies disrupt the normal development of the chick retina.

Authors:  P Bovolenta; J M Frade; E Martí; M A Rodríguez-Peña; Y A Barde; A Rodríguez-Tébar
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

5.  Blot and culture analysis of neuronotrophic factors in nerve regeneration chamber fluids.

Authors:  D J Bates; J A Ranford; D C Mangelsdorf
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

Review 6.  BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death.

Authors:  Y T Ma; T Hsieh; M E Forbes; J E Johnson; D O Frost
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

Review 7.  Promoting and directing axon outgrowth.

Authors:  D P Kuffler
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

8.  Expression of specific tubulin isotypes increases during regeneration of injured CNS neurons, but not after the application of brain-derived neurotrophic factor (BDNF).

Authors:  A E Fournier; L McKerracher
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

9.  Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo.

Authors:  B Lom; S Cohen-Cory
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 10.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.